Biolife Solutions (BLFS) Net Cash Flow (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Net Cash Flow data on file, last reported at -$10.2 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 64.08% year-over-year to -$10.2 million in Q1 2026; TTM through Mar 2026 was -$44.1 million, a 218.75% decrease from a year earlier, with the FY2025 full-year figure at -$62.3 million, down 204.0% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$10.2 million, down from $3.6 million in the prior quarter.
• Over the last five years, Net Cash Flow for BLFS reached as high as $71.2 million in Q4 2024 and fell as low as -$35.3 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$2.8 million across 5 years, with a median of -$2.4 million in 2025.
• Across the five-year window, Net Cash Flow jumped 407.94% in 2022 and tumbled 1522.99% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at -$7.7 million in 2022, then soared by 310.25% to $16.1 million in 2023, then soared by 341.96% to $71.2 million in 2024, then plunged by 95.0% to $3.6 million in 2025, then tumbled by 387.21% to -$10.2 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$10.2 million in Q1 2026, $3.6 million in Q4 2025, and -$2.4 million in Q3 2025.